Abstract
1 Caroverine fumarate, 1-(2-diethylaminoethyl)-3-(p-methoxy-benzyl)-1,2-dihydro-2-quinoxalinone fumarate, caused a greater inhibition of the pressor response to KCl (8 x 10(-2) M) than that to noradrenaline (10(-6) M) in the rat hindquarter preparation. 2 In the isolated aorta of the rat, caroverine (up to 10(-6) M) markedly suppressed the contraction caused by KCl (4 x 10(-2) M) (high-K) but had little effect on the contractile response to noradrenaline (10(-6) M) whether added before the spasmogen or in its presence. 3 In the high-K-treated aorta, caroverine shifted the concentration-response curve for external calcium to the right, competitively. The negative logarithm of the affinity (pA2) of caroverine was calculated to be approx. 7. 4 Increased 45Ca uptake of the high-K-treated aorta measured by a modified lanthanum method was inhibited by either caroverine (3 x 10(-6) M) or verapamil (10(-6) M). 5 Concentrations of caroverine and verapamil reducing high-K-induced aortic contraction to 50% of its maximum were 2.4 x 10(-7) and 6.6 x 10(-8) M respectively. 6 Following washout the caroverine-induced inhibition of high-K-induced aortic contraction was more rapidly restored than the verapamil-induced inhibition. 7 These results suggest that caroverine fumarate is a specific and readily reversible calcium influx inhibitor in the rat vascular smooth muscle.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Golenhofen K., Hermstein N. Differentiation of calcium activation mechanisms in vascular smooth muscle by selective suppression with verapamil and D 600-1. Blood Vessels. 1975;12(1):21–37. doi: 10.1159/000158036. [DOI] [PubMed] [Google Scholar]
- HORNYKIEWICZ O., HITZENBERGER G., ZELLNER H. [Experimental-pharmacological and clinical studies on a new spasmolytic "Spadon" (test name P 201-1)]. Wien Klin Wochenschr. 1963 Mar 15;75:189–passim. [PubMed] [Google Scholar]
- Karaki H., Kubota H., Urakawa N. Mobilization of stored calcium for phasic contraction induced by norepinephrine in rabbit aorta. Eur J Pharmacol. 1979 Jun 15;56(3):237–245. doi: 10.1016/0014-2999(79)90176-6. [DOI] [PubMed] [Google Scholar]
- Kohlhardt M., Bauer B., Krause H., Fleckenstein A. Differentiation of the transmembrane Na and Ca channels in mammalian cardiac fibres by the use of specific inhibitors. Pflugers Arch. 1972;335(4):309–322. doi: 10.1007/BF00586221. [DOI] [PubMed] [Google Scholar]
- Massingham R. A study of compounds which inhibit vascular smooth muscle contraction. Eur J Pharmacol. 1973 Apr;22(1):75–82. doi: 10.1016/0014-2999(73)90186-6. [DOI] [PubMed] [Google Scholar]
- Peiper U., Griebel L., Wende W. Activation of vascular smooth muscle of rat aorta by noradrenaline and depolarization: two different mechanisms. Pflugers Arch. 1971;330(1):74–89. doi: 10.1007/BF00588736. [DOI] [PubMed] [Google Scholar]
- VAN ROSSUM J. M. Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Ther. 1963;143:299–330. [PubMed] [Google Scholar]
- Van Breemen C., Farinas B. R., Gerba P., McNaughton E. D. Excitation-contraction coupling in rabbit aorta studied by the lanthanum method for measuring cellular calcium influx. Circ Res. 1972 Jan;30(1):44–54. doi: 10.1161/01.res.30.1.44. [DOI] [PubMed] [Google Scholar]